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Background: The activation of liver X receptor (LXR) a or LXRb negatively regulates the expression of pro-
inﬂammatory genes in mammalian cells. We recently reported that 25-hydroxycholesterol, a represen-
tative LXR-activating oxysterol, suppresses IL-6 production in mouse mast cells (MCs) following its
engagement of the high-afﬁnity IgE receptor (FcεRI). This ﬁnding suggests that murine MCs express
functional LXRs; however, the mechanisms underlying the LXR-dependent repression of the MC-
mediated production of pro-inﬂammatory cytokines, including IL-6, are poorly understood. Therefore,
we employed the synthetic LXR ligand GW3965 to examine the functions of LXRa and LXRb in the
production of pro-inﬂammatory cytokines by murine bone marrow-derived MCs (BMMCs).
Methods: We prepared BMMCs from wild-type (WT), LXRa/, and LXRa/b/ mice. Each group of
BMMCs was pretreated with GW3965 and then stimulated with IgEþantigen (Ag) or lipopolysaccharide
(LPS). Cytokine production was then analyzed using speciﬁc ELISA kits.
Results: The activation of LXRs by GW3965 signiﬁcantly attenuated the production of IL-1a and IL-1b, but
not of IL-6, in the WT and LXRa/ BMMCs stimulated with IgEþAg. However, GW3965 treatment
decreased the production of IL-1a, IL-1b, and IL-6 in WT and LXRa/ BMMCs upon stimulation with LPS,
while the GW3965-mediated suppression of cytokine production was nearly absent from the LXRa/b/
BMMCs.
Conclusions: These ﬁndings demonstrate, for the ﬁrst time, that the activation of LXRs by GW3965 at-
tenuates the antigen- or LPS-induced production of pro-inﬂammatory cytokines, such as IL-1a and IL-1b,
in murine MCs and that LXRb plays an important role in the LXR-mediated repression of cytokine
production.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. All rights reserved.Introduction
Liver X receptor (LXR) a and LXRb are representative nuclear
receptors that were previously reported to negatively regulate the
expression of pro-inﬂammatory genes in different types of
mammalian cells, including macrophages,1e3 T cells,4 astrocytes,5
synoviocytes,6 and airway smooth muscle cells.7 Furthermore,gy, Allergy and Immunology
niversity School of Medicine,
Japan.
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rgology. Production and hosting by Elstopical or systemic administration of natural or synthetic LXR li-
gands resulted in the amelioration of glomerulonephritis,8 allergic
dermatitis,9,10 chronic asthma,11 and multiple sclerosis12,13 in
experimental animal models. These ﬁndings suggest that the
regulation of LXR activation in immune cells represents a promising
therapeutic strategy for the above-mentioned immune disorders.
Mast cell (MC)-produced pro-inﬂammatory cytokines
contribute to the pathogenesis of various chronic allergic and
autoimmune disorders. Therefore, elucidating the biological
mechanisms underlying LXR activation that reduce cytokine
expression in MCs is valuable. Previously, we reported that 25-
hydroxycholesterol (OHC), a natural LXR agonist, suppressed the
production of the IL-6 protein inmurineMCs activated via the high-evier B.V. All rights reserved.
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functions in lipid metabolism. In addition to activating LXRs, oxy-
sterols regulate the synthesis of cholesterol esters15e17 and the
activation of HMG-CoA reductase.18,19 Indeed, treatment of MCs
with 25-OHC considerably decreased the cell surface expression of
FcεRI in an LXR-independent manner.14 Thus, it is unclear whether
LXR activation directly suppresses FcεRI-dependent cytokine
expression in MCs. To clarify the mechanisms by which LXRa and
LXRb are involved in the suppression of pro-inﬂammatory cytokine
production, we employed GW3965, a widely used synthetic ligand
that is speciﬁc for LXRa and LXRb.1,6,9,20,21
In this study, we found that treatment of murine bone marrow-
derived MCs (BMMCs) with GW3965 decreased their IgEþantigen
(Ag)- or LPS-stimulated cytokine expression. Furthermore, we
investigated the functions of LXRa and LXRb in the GW3965-
mediated repression of cytokine expression.
Methods
Regents
GW3965, dexamethasone (DEX), and LPS (Escherichia coli 0111:
B4) were obtained from Sigma (St. Louis, MO, USA). Mouse anti-TNP
IgE (IgE-3) and TNP-BSA (25 mol TNP per mol BSA) were purchased
from BD Biosciences (San Diego, CA, USA) and BIOSEARCH Tech-
nologies (Petaluma, CA, USA), respectively. Recombinant murine IL-
3 was obtained from PeproTech (Rocky Hill, NJ, USA), and PE-
conjugated anti-mouse c-kit mAb (2B8), FITC/PerCP-conjugated
anti-mouse FcεRIa mAb (MAR-1), and all ELISA kits were pur-
chased from Affymetrix eBioscience (San Diego, CA, USA). RabbitFig. 1. The effects of GW3965 on the IgEþAg or LPS-induced production of IL-1a, IL-1b, IL-6
GW3965 for 1 h and then stimulated with 2 ng/ml TNP-BSA (A) or 1 mg/ml LPS (B) for 6 h
(Student's t-test). Similar results were obtained from three independent experiments.anti-mouse LXRb (N20) and b-actin (N21) polyclonal antibodies
were purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
Animals
The LXRa/ and LXRb/ mice were provided by Dr. Man-
gelsdorf22 and were backcrossed with C57BL/6J mice for at least
eight generations; the LXRa/b/ mice were generated from the
LXRa/ and LXRb/ mice. The mice were bred in the animal fa-
cility of the Nihon University School of Medicine under speciﬁc
pathogen-free conditions. Wild-type (WT) C57BL/6J mice were
obtained from Charles River Laboratories Japan (Kanagawa, Japan)
and served as a wild-type control for the LXRa/ and LXRa/b/
mice. Following approval by the animal experimentation commit-
tee at Nihon University, all of the experiments were performed in
accordance with the guidelines for the care and use of laboratory
animals of Nihon University.
Cell culture
The BMMC cultures were prepared from the femurs of mice as
previously described,17 and after six to eight weeks in culture, the
BMMCs were used for experiments
GeneChip expression analysis
Murine genome-wide gene expression was assessed using the
Mouse4 Genome 430 2.0 probe array (GeneChip, Affymetrix, Santa
Clara, CA, USA), which contains an oligonucleotide probe set for
approximately 39,000 full-length genes and ESTs, according to the, and TNF-a by MCs. The IgE-sensitized WT BMMCs were treated with or without 1 mM
. The data are presented as the means ± SDs of quadruplicate experiments. *p < 0.05
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Manual) and as described in previous reports.23 The obtained data
were analyzed using GeneSpring software, version GX 11.5 (Silicon
Genetics, San Carlos, CA, USA). To normalize the staining intensity
variations among the chips, the average differences for all of the
genes on a given chip were divided by the median of all of the
measurements on that chip. Based on these normalized values, the
genes were classiﬁed as up-regulated (shown in red) or down-
regulated (shown in green).
Measurement of cytokine production
BMMCs (1 107) were sensitized overnight with 0.5 mg/ml anti-
TNP IgE, and then 1 106 of the sensitized cells were washed twice
with PBS and pretreated with 1 mM GW3965 or DMSO (vehicle) for
1 h. The pretreated cells were then stimulated with 2 ng/ml TNP-
BSA or 1 mg/ml LPS for 6 h. To detect spontaneous cytokine pro-
duction, the cells were cultured in the absence of TNP-BSAor LPS for
6 h, and the levels of IL-6 and TNF-a in the supernatants and of IL-1a
and IL-1b in the cell lysates were analyzed using speciﬁc ELISA kits.
The data are presented as the net production levels of each cytokine.
Degranulation assay
The IgE-sensitized BMMCs (1  105) were washed twice with
PBS and then stimulated with or without 2 ng/ml TNP-BSA forFig. 2. The effects of GW3965 on the IgEþAg or LPS-induced production of IL-1a and IL-1b
BMMCs. The results are representative of three independent experiments, which produced
sensitized WT and LXRa/ BMMCs were stimulated with 2 ng/ml TNP-BSA for 0.5 h. A23187
the Methods section. (C) The IgE-sensitized WT and LXRa/ BMMCs were treated with or w
LPS (D) for 6 h. In (B)e(D), the data are presented as the means ± SDs of quadruplicate ex
pendent experiments.30 min; A23187 (1 mM) was used as a non-immunological control.
Degranulation was determined by measuring b-hexosaminidase
release, as described previously,24 and the results are presented as
the percentage of released b-hexosaminidase, whichwas calculated
as follows: (optical density of the supernatant from the cells)/(op-
tical density of the total cell lysate)  100.
Flow cytometric analyses
The BMMCs (1  105) were labeled with a PE-conjugated anti-
mouse c-kit mAb and an FITC/PerCP-conjugated anti-mouse FcεRIa
mAb at 4 C for 30 min. After washing with PBS, the labeled cells
were analyzed using a FACSCalibur (BD Biosciences).
Immunoblotting
The BMMCs (1  106) were lysed in lysis buffer (Tris-buffered
saline containing 1% Nonidet P-40, 2 mM phenyl-
methanesulfonylﬂuoride,10 mg/ml aprotinin, 2 mg/ml leupeptin and
2 mg/ml pepstatin A) for 30 min on ice, centrifuged for 15 min at
15,000 g and resuspended in an equal volume of 2 Laemmli buffer.
Then, the samples were boiled, separated on a 12% SDS-PAGE gel,
and transferred to an Immobilon-P membrane (Merck Millipore,
Bedford, MA, USA). The membrane was incubated with a rabbit
anti-mouse LXRb or b-actin polyclonal antibody followed by a
horseradish peroxidase-conjugated goat anti-rabbit IgG secondaryby LXRa/ BMMCs. (A) Comparable expression of FcεRI and c-kit in WT and LXRa/
similar results. (B) The degranulation response was unaltered in LXRa/ BMMCs. IgE-
was used as a positive control. b-hexosaminidase release was analyzed as described in
ithout 1 mM GW3965 for 1 h and then stimulated with 2 ng/ml TNP-BSA (C) or 1 mg/ml
periments. *p < 0.05 (Student's t-test). Similar results were obtained from three inde-
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iluminescence (GE Healthcare Life Sciences, Tokyo, Japan).
Statistical analysis
The data are presented the means ± SD of at least three replicate
samples. Statistical analysis was performed using Student's t-test,
and probability values of less than 0.05 indicated signiﬁcant
differences.
Results
GW3965 attenuates the expression of mRNAs for IL-1a, IL-1b, IL-3,
and IL-5 following FcεRI stimulation
First, we examined the effects of GW3965 on the expression of
pro-inﬂammatory cytokine mRNAs in BMMCs via GeneChip
expression analysis (Supplementary Fig. 1); DEX, a synthetic ligand
of glucocorticoid receptors, was used as a positive control. Micro-
array analyses clearly indicated that DEX considerably suppressed
the mRNA expression of 11 cytokines (IL-1a, IL-1b, IL-2, IL-3, IL-4,
IL-5, IL-6, IL-13, IL-31, IL-33, and TNF-a) that was induced by IgE-
þAg stimulation. In contrast, GW3965 failed to decrease the mRNA
expression of IL-2, IL-4, IL-6, IL-13, IL-31, IL-33, or TNF-a but slightly
or modestly reduced the mRNA expression of IL-1a, IL-1b, IL-3, and
IL-5. These data suggest that GW3965 suppresses the expression of
fewer cytokines than DEX.Fig. 3. LXRa/b/ BMMCs exhibit a normal degranulation response upon FcεRI stimulati
Representative alcian blue/safranin O staining. (C) Western blot analysis of LXRb expressio
produced similar results. (D) IgE-sensitized WT and LXRa/b/ BMMCs were stimulated w
hexosaminidase release was analyzed, and the data are presented as the means ± SDs of tripGW3965 attenuates the protein expression of IL-1a and IL-1b
following FcεRI stimulation
Of the cytokine genes induced by IgEþAg stimulation, the
expression of IL-1, IL-6, and TNF-a was induced in murine MCs
upon stimulation with LPS.25e27 Thus, we examined the effects of
GW3965 on the IgEþAg- or LPS-induced protein expression of IL-
1a, IL-1b, IL-6, and TNF-a. Consistent with our microarray data,
GW3965 signiﬁcantly attenuated the protein expression of IL-1a
and IL-1b, but not of IL-6 or TNF-a, in MCs stimulated by IgEþAg
(Fig. 1A). In addition to IL-1a and IL-1b, IL-6 protein expression was
suppressed in GW3965-treatedMCs following stimulationwith LPS
(Fig. 1B).LXRa is not required for the GW3965-mediated repression of
cytokine production
To elucidate the biological function of LXRa in the GW3965-
mediated repression of cytokine production, we prepared BMMCs
from mice lacking LXRa. The LXRa/ BMMCs displayed typical
FcεRI and c-kit expression and degranulated in response to stim-
ulation with IgE þ Ag (Fig. 2A, B). Fig. 2C, D indicate that GW3965
reduced the production of IL-1a and IL-1b in LXRa/ BMMCs in
response to IgE þ Ag or LPS stimulation. These results suggest that
LXRa is not responsible for the GW3965-mediated repression of
cytokine production in BMMCs.on. (A) Comparable expression of FcεRI and c-kit in WT and LXRa/b/ BMMCs. (B)
n. In (A)e(C), the results are representative of three independent experiments, which
ith or without 2 ng/ml TNP-BSA for 0.5 h; A23187 was used as a positive control. b-
licate experiments. Similar results were obtained from three independent experiments.
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murine MCs to stimulation by FcεRI
Similar to the LXRa/ BMMCs, the LXRa/b/ BMMCs expressed
typical levels of FcεRI and c-kit (Fig. 3A). In addition, alcian blue/
safranin O staining indicated that the maturity of the MCs was
comparable between the WT and LXRa/b/ BMMCs (Fig. 3B). We
also conﬁrmed that the LXRa/b/ BMMCs indeed lacked LXRb
expression (Fig. 3C). As shown in Fig. 3D, the FcεRI-induced
degranulation responsewas not impaired in the LXRa/b/ BMMCs.
These results suggest that LXRa and LXRb are not essential for the
degranulation response of MCs to stimulation by FcεRI.
LXRa/b/ BMMCs are protected from the GW3965-mediated
repression of cytokine production
Finally, we examined the effects of GW3965 on the expression of
IL-1a, IL-1b, and IL-6 in LXRa/b/ BMMCs stimulated with IgEþAg
or LPS. Following stimulation with IgEþAg or LPS, GW3965 did not
exert any suppressive effects on cytokine production by LXRa/b/
BMMCs (Fig. 4A, B).
Discussion
In the present study, we have shown that the activation of LXRs
by GW3965 resulted in the down-regulation of IL-1 and/or IL-6Fig. 4. The effects of GW3965 on the IgEþAg or LPS-induced expression of IL-1a, IL-1b, and
or without 1 mM GW3965 for 1 h and then stimulated with 2 ng/ml TNP-BSA (A) or 1 mg/ml
experiments. *p < 0.05 (Student's t-test). Similar results were obtained from three indepenexpression in murine MCs stimulated with IgEþAg or LPS.
Because the inhibitory effects of GW3965 on cytokine expression
were nearly absent from LXRa/b/, but not LXRa/, BMMCs
(Fig. 4), we conclude that LXRb plays a crucial role in the GW3965-
mediated repression of cytokine production. We and others inde-
pendently reported that murine MCs predominantly express LXRb,
but not LXRa.14,28 Therefore, we speculate that differences in the
LXRb and LXRa expression levels may explain why LXRa is not
required for the LXR-mediated repression of cytokine expression. In
addition, the knockout of LXRa and LXRb did not signiﬁcantly affect
MC differentiation, FcεRI expression, or the degranulation response,
as shown in Fig. 3. The inability of LXRs to regulate FcεRI expression
and degranulation may be supported by our previous report, which
demonstrated that FcεRI expression and FcεRI-induced degranula-
tion are not altered in the presence of the synthetic LXR agonist
T0901317.14 Collectively, these ﬁndings indicate that the activation
of LXRa and LXRb does not interfere with the molecular mecha-
nisms underlying FcεRI expression or the degranulation response of
MCs.
In the absence of GW3965, we found that IgEþAg-induced
production of IL-1b, as illustrated in Fig. 2C, and LPS-induced pro-
ductions of IL-1a and IL-6, as seen in Fig. 4B, were signiﬁcantly
decreased in the LXRa/ and LXRa/b/ MCs, respectively. We
currently speculate that, in the absence of LXRs, the pro-longed
culture of MCs interferes with cholesterol homeostasis and cyto-
kine responses for the following reasons: (i) six to eight weeks wereIL-6 by LXRa/b/ BMMCs. IgE-sensitized WT and LXRa/b/ BMMCs were treated with
LPS (B) for 6 h. In (A)e(B), the data are presented as the means ± SDs of quadruplicate
dent experiments.
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intracellular cholesterol by increasing cholesterol efﬂux29; and (iii)
the shortage of intracellular cholesterol results in the constitutive
up-regulation of cytokine production in MCs.30
As we demonstrated, BMMCs produced substantial amounts of
IL-6 protein upon stimulation by IgEþAg or LPS; however, the
activation of LXRs by GW3965 failed to suppress the IgEþAg-
induced production of IL-6 (Fig. 1). In this study, we did not fully
elucidate the distinct effects of GW3965 on IL-6 production. In
macrophages, the GW3965-dependent repression of pro-
inﬂammatory gene expression in response to LPS is regulated by
the LXR-mediated stabilization of the co-repressor complex.31
Ghisletti et al. reported that GW3965 stabilizes the binding of the
co-repressor complex to the IL-1b promoter in response to LPS but
fails to stabilize the co-repressor complex when the cells are
stimulated by Poly I:C.32 Future analysis of the binding of the co-
repressor complex to the IL-6 promoter in MCs is required to
explain the different sensitivities of the IL-6 gene to GW3965 when
activated by distinct stimuli.
Previous studies employing mouse models suggested that the
MC-mediated expression of IL-1b is essential for the development
of inﬂammatory arthritis33,34 and cryopyrin-associated periodic
syndrome.35 We expect that the administration of LXR agonists
may have exerted suppressive effects on arthritic and skin
inﬂammation in these experimental animals. Furthermore, epi-
cutaneous application of LXR agonists ameliorated murine chronic
atopic dermatitis by decreasing dermal Th2 inﬂammation, for
example, the inﬁltration of eosinophils, mast cells, and Th2-posi-
tive lymphocytes.10 Regarding the cytokines associated with Th2-
mediated inﬂammation, the FcεRI-induced gene expression of IL-5,
which is critical for the differentiation and proliferation of human
and murine eosinophils,36 was down-regulated in the presence of
GW3965 treatment (Supplementary Fig. 1). Thus, it is likely that
the LXR-mediated repression of IL-5 expression in MCs decreases
the number of eosinophils in the dermis; however, the mecha-
nisms by which MC-produced IL-5 promotes atopic skin inﬂam-
mation in eosinophilia remain unclear. MC-produced IL-6 is
required for LPS-induced lung inﬂammatory responses37 and the
TLR2-mediated inhibition of tumor growth,38 and it protects the
host from lethal sepsis by recruiting neutrophils.39 Thus, MC-
produced IL-6 exerts beneﬁcial effects in vivo. However, treat-
ment of MCs with GW3965 resulted in a reduction in LPS-induced
IL-6 production. Therefore, we propose that the careful adminis-
tration of LXR agonists to experimental animals in vivo should be
performed in the future.
In conclusion, we addressed the biological roles of LXRa and
LXRb in the LXR-dependent repression of pro-inﬂammatory cyto-
kine expression in murine MCs, and our ﬁndings deepen our un-
derstanding of MCs and of the functions of LXRs.Acknowledgments
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